Cegedim SA (EPA:ALCGM)
10.30
-0.22 (-2.09%)
Oct 22, 2026, 5:35 PM CEST
Cegedim Market Cap
Cegedim has a market cap or net worth of €141.43 million as of October 22, 2026. It is the 22,061st most valuable company in the world and the 261st biggest in France. Its market cap has decreased by 8.29% in one year.
Market Cap
141.43M
Enterprise Value
400.52M
Revenue
651.52M
Global Rank
Country Rank
#261 France
PE Ratio
10.34
ChartMarket Cap Chart
Since November 7, 1995, Cegedim's market cap has increased from 113.85M to 141.43M, an increase of 24.22%. That is a compound annual growth rate of 0.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 141.43M | -24.19% |
| Dec 31, 2025 | 186.56M | 6.71% |
| Dec 31, 2024 | 174.83M | -28.22% |
| Dec 29, 2023 | 243.57M | 22.47% |
| Dec 30, 2022 | 198.89M | -39.93% |
| Dec 31, 2021 | 331.11M | -6.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 88.14B |
| EssilorLuxottica Société anonyme | 79.88B |
| Sartorius Stedim Biotech | 20.96B |
| Eurofins Scientific SE | 14.04B |
| Valerio Therapeutics Société anonyme | 200.28M |
| Transgene | 185.69M |
| Median Technologies | 161.82M |
| Bastide Le Confort Médical | 136.98M |